RU2001110355A - NON-INFLUENCE OF FOOD PHARMACEUTICAL DOSED DRUG FORMS OF LONG-TERM ACTION CONTAINING MANY UNITS, AND METHOD FOR PRODUCING THEM - Google Patents
NON-INFLUENCE OF FOOD PHARMACEUTICAL DOSED DRUG FORMS OF LONG-TERM ACTION CONTAINING MANY UNITS, AND METHOD FOR PRODUCING THEMInfo
- Publication number
- RU2001110355A RU2001110355A RU2001110355/14A RU2001110355A RU2001110355A RU 2001110355 A RU2001110355 A RU 2001110355A RU 2001110355/14 A RU2001110355/14 A RU 2001110355/14A RU 2001110355 A RU2001110355 A RU 2001110355A RU 2001110355 A RU2001110355 A RU 2001110355A
- Authority
- RU
- Russia
- Prior art keywords
- polymer
- active substance
- mixture
- particles
- formulation according
- Prior art date
Links
- 229940079593 drugs Drugs 0.000 title claims 4
- 239000003814 drug Substances 0.000 title claims 3
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 239000000203 mixture Substances 0.000 claims 19
- 229920000642 polymer Polymers 0.000 claims 9
- 239000000126 substance Substances 0.000 claims 9
- 238000009472 formulation Methods 0.000 claims 8
- 239000002245 particle Substances 0.000 claims 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 4
- 230000002459 sustained Effects 0.000 claims 4
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims 2
- 239000011805 ball Substances 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000001125 extrusion Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000008185 minitablet Substances 0.000 claims 1
- 230000002035 prolonged Effects 0.000 claims 1
- 230000000979 retarding Effects 0.000 claims 1
- 230000001340 slower Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000002966 varnish Substances 0.000 claims 1
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19842753.0 | 1998-09-18 | ||
DE19842753A DE19842753A1 (en) | 1998-09-18 | 1998-09-18 | Multiple-unit retard oral dosage formulation having controlled release independent of agitation and food effect, containing particles of combination of drug and hydroxypropyl cellulose |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001110355A true RU2001110355A (en) | 2003-03-10 |
RU2235540C2 RU2235540C2 (en) | 2004-09-10 |
Family
ID=7881376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001110355/15A RU2235540C2 (en) | 1998-09-18 | 1999-09-17 | Method for preparing oral preparative form with prolonged effect and regulated release of active substance depending on species and amount of stomach and digestive tract filling |
Country Status (29)
Country | Link |
---|---|
US (1) | US6805881B1 (en) |
EP (1) | EP1113787B1 (en) |
JP (1) | JP2002526437A (en) |
KR (1) | KR100660072B1 (en) |
CN (1) | CN1178650C (en) |
AT (1) | ATE260645T1 (en) |
AU (2) | AU5861499A (en) |
BG (1) | BG105325A (en) |
BR (1) | BR9913839A (en) |
CA (1) | CA2344372C (en) |
DE (2) | DE19842753A1 (en) |
DK (1) | DK1113787T3 (en) |
EE (1) | EE04700B1 (en) |
ES (1) | ES2215404T3 (en) |
HK (1) | HK1040932B (en) |
HR (1) | HRP20010198A2 (en) |
HU (1) | HUP0103669A3 (en) |
ID (1) | ID28735A (en) |
IL (2) | IL141532A0 (en) |
NO (1) | NO20011211L (en) |
NZ (1) | NZ510563A (en) |
PL (1) | PL195543B1 (en) |
PT (1) | PT1113787E (en) |
RU (1) | RU2235540C2 (en) |
SK (1) | SK285099B6 (en) |
TR (1) | TR200100756T2 (en) |
UA (1) | UA73097C2 (en) |
WO (2) | WO2000016747A1 (en) |
ZA (1) | ZA200101485B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (en) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituted oxazolidinones and their use |
DE10026698A1 (en) | 2000-05-30 | 2001-12-06 | Basf Ag | Self-emulsifying active ingredient formulation and use of this formulation |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
DE10129725A1 (en) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Combination therapy of substituted oxazolidinones |
AR034813A1 (en) † | 2001-07-20 | 2004-03-17 | Novartis Ag | PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME |
DE10300111A1 (en) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
DE10355461A1 (en) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases |
DE102004062475A1 (en) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Solid, orally administrable, modified release pharmaceutical dosage forms |
BRPI0518396A2 (en) | 2004-12-27 | 2008-11-18 | Eisai R&D Man Co Ltd | Anti-Dementia Drug Stabilization Method |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
DE102005012561B4 (en) | 2005-03-18 | 2008-06-19 | Christian Beer | Method for operating a workpiece transfer system |
DE102005045518A1 (en) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa |
DE102005047558A1 (en) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Combination therapy of substituted oxazolidinones for the prophylaxis and treatment of cerebral circulatory disorders |
DE102005047561A1 (en) * | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance |
BRPI0616801B8 (en) | 2005-10-04 | 2021-05-25 | Bayer Healthcare Ag | "polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl )-2-thiophenecarboxamide, its preparation processes and its uses, medicine, and process for preventing blood clotting in vitro |
CN100448432C (en) * | 2006-10-26 | 2009-01-07 | 徐竹青 | Method for preparing nimodipine dispersible tablet with high dissolution |
DE102006051625A1 (en) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Combination therapy of substituted oxazolidinones |
US7952167B2 (en) * | 2007-04-27 | 2011-05-31 | Taiwan Semiconductor Manufacturing Company, Ltd. | Scribe line layout design |
PT2391345E (en) * | 2009-01-28 | 2014-12-03 | Novartis Ag | Galenic formulations comprising aliskiren |
US20100247646A1 (en) * | 2009-03-26 | 2010-09-30 | Ranbaxy Laboratories Limited | Extended release tablets of nisoldipine |
EP2554168B1 (en) | 2010-03-29 | 2018-01-24 | Astellas Pharma Inc. | Controlled release pharmaceutical composition |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5482525A (en) | 1977-12-13 | 1979-06-30 | Aisan Ind Co Ltd | Exhaust gas recirculation system |
US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4449983A (en) | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
GB8514665D0 (en) * | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
DE3612211A1 (en) | 1986-04-11 | 1987-10-15 | Basf Ag | CONTINUOUS TABLET METHOD |
DE3612212A1 (en) | 1986-04-11 | 1987-10-15 | Basf Ag | METHOD FOR PRODUCING SOLID PHARMACEUTICAL FORMS |
DE3720757A1 (en) | 1987-06-24 | 1989-01-05 | Bayer Ag | DHP COAT TABLET |
DE3830353A1 (en) | 1988-09-07 | 1990-03-15 | Basf Ag | METHOD FOR THE CONTINUOUS PRODUCTION OF SOLID PHARMACEUTICAL FORMS |
JPH03145418A (en) | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | Sustained release preparation of basic drug hydrochloride |
KR0182801B1 (en) | 1991-04-16 | 1999-05-01 | 아만 히데아키 | Method of manufacturing solid dispersion |
DE4138513A1 (en) | 1991-11-23 | 1993-05-27 | Basf Ag | SOLID PHARMACEUTICAL RETARD FORM |
DE4413350A1 (en) | 1994-04-18 | 1995-10-19 | Basf Ag | Retard matrix pellets and process for their production |
SE9402422D0 (en) * | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
FR2725624B1 (en) | 1994-10-14 | 1997-01-17 | Jouveinal Inst Rech | PROCESS FOR THE PREPARATION OF CONTROLLED RELEASE PHARMACEUTICAL FORMS |
DE19504831A1 (en) | 1995-02-14 | 1996-09-05 | Basf Ag | Solid active substance preparations containing hydroxypropyl cellulose |
-
1998
- 1998-09-18 DE DE19842753A patent/DE19842753A1/en not_active Withdrawn
-
1999
- 1999-09-08 WO PCT/EP1999/006608 patent/WO2000016747A1/en active Application Filing
- 1999-09-08 AU AU58614/99A patent/AU5861499A/en not_active Abandoned
- 1999-09-17 BR BR9913839-5A patent/BR9913839A/en not_active Application Discontinuation
- 1999-09-17 ID IDW20010651A patent/ID28735A/en unknown
- 1999-09-17 DE DE59908764T patent/DE59908764D1/en not_active Expired - Lifetime
- 1999-09-17 NZ NZ510563A patent/NZ510563A/en unknown
- 1999-09-17 US US09/787,229 patent/US6805881B1/en not_active Expired - Fee Related
- 1999-09-17 WO PCT/EP1999/006882 patent/WO2000016748A1/en active IP Right Grant
- 1999-09-17 ES ES99948770T patent/ES2215404T3/en not_active Expired - Lifetime
- 1999-09-17 JP JP2000573709A patent/JP2002526437A/en not_active Ceased
- 1999-09-17 CA CA002344372A patent/CA2344372C/en not_active Expired - Fee Related
- 1999-09-17 PL PL99346535A patent/PL195543B1/en unknown
- 1999-09-17 TR TR2001/00756T patent/TR200100756T2/en unknown
- 1999-09-17 EP EP99948770A patent/EP1113787B1/en not_active Expired - Lifetime
- 1999-09-17 CN CNB998110299A patent/CN1178650C/en not_active Expired - Fee Related
- 1999-09-17 DK DK99948770T patent/DK1113787T3/en active
- 1999-09-17 HU HU0103669A patent/HUP0103669A3/en unknown
- 1999-09-17 EE EEP200100161A patent/EE04700B1/en not_active IP Right Cessation
- 1999-09-17 KR KR1020017003495A patent/KR100660072B1/en not_active IP Right Cessation
- 1999-09-17 AT AT99948770T patent/ATE260645T1/en not_active IP Right Cessation
- 1999-09-17 PT PT99948770T patent/PT1113787E/en unknown
- 1999-09-17 RU RU2001110355/15A patent/RU2235540C2/en not_active IP Right Cessation
- 1999-09-17 UA UA2001042576A patent/UA73097C2/en unknown
- 1999-09-17 AU AU61918/99A patent/AU750617B2/en not_active Ceased
- 1999-09-17 SK SK372-2001A patent/SK285099B6/en unknown
- 1999-09-17 IL IL14153299A patent/IL141532A0/en not_active IP Right Cessation
-
2001
- 2001-02-20 IL IL141532A patent/IL141532A/en unknown
- 2001-02-22 ZA ZA200101485A patent/ZA200101485B/en unknown
- 2001-03-09 BG BG105325A patent/BG105325A/en unknown
- 2001-03-09 NO NO20011211A patent/NO20011211L/en not_active Application Discontinuation
- 2001-03-16 HR HR20010198A patent/HRP20010198A2/en not_active Application Discontinuation
-
2002
- 2002-04-11 HK HK02102756.8A patent/HK1040932B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001110355A (en) | NON-INFLUENCE OF FOOD PHARMACEUTICAL DOSED DRUG FORMS OF LONG-TERM ACTION CONTAINING MANY UNITS, AND METHOD FOR PRODUCING THEM | |
JP2720932B2 (en) | Method for producing acetaminophen tablet for oral administration and bilayer tablet of acetaminophen | |
CN100353933C (en) | Instant oral medincinal preparation | |
RU2204996C2 (en) | Tablet rapidly decomposing into buccal pocket and method of its making | |
JP5777170B2 (en) | Fast dissolving solid dosage form | |
CA2344372A1 (en) | Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same | |
EA001537B1 (en) | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a great amount of medicaments | |
WO2001089483A9 (en) | Tablets and methods for modified release of hydrophilic and other active agents | |
SE453796B (en) | FIXED, THERAPEUTIC COMPOSITION OUR BEARING MATERIAL IS MADE OF HYDROXYPROPYLMETHYL CELLULOSA AND EVEN SODIUM CARBOXYMETHYL CELLULOSA | |
UA72207C2 (en) | Pharmaceutical formulations of efavirenz and disintegrants providing for increasing dissolution rate and process of manufacturing such tablets or capsules | |
SE453797B (en) | THERAPEUTIC, SOLID UNIT DOSAGE FORM WITH EXTENDED DISPOSAL SAMPLES WHERE BERARM MATERIALS INCLUDE HYDROXYPROPYLMETHYL CELLULOSA WITH HIGH MOLECULES WEIGHT | |
JPH01250314A (en) | Gradual release agent | |
JP2007532620A (en) | Pharmaceutical composition comprising amphiphilic starch | |
TW201022253A (en) | Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low pH and methods of use thereof | |
CA2182004C (en) | Film coated tablet of paracetamol and domperidone | |
EA006103B1 (en) | Paracetamol pharmaceutical composition | |
JP2011148816A (en) | Rapidly disintegratable tablet in oral cavity | |
JP2006070046A (en) | Quick disintegrable solid preparation | |
WO2006115770A2 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
US20040037880A1 (en) | Extended release formulation of divalproex sodium | |
JPH03500288A (en) | Extended release nifedipine formulation | |
JP2011246428A (en) | Orally disintegrating medicine and production method | |
JP3274416B2 (en) | Orally disintegrating granular preparation | |
RU2411035C2 (en) | Modified release 6-methyl-2-ethyl-hydroxypyridine succinate dosage form | |
Pandit et al. | FORMULATION AND IN VITRO EVALUATION |